Prenatal and Newborn Genetic Testing Market Outlook to 2027 - Top Companies Abbott, Oxford Gene Technology, Ravgen, Bio-Rad Laboratories, Illumina, SOPHiA GENETICS, PerkinElmer, SEBIA, Sequenom, and Natera

Prenatal genetic testing is performed during the pregnancy for the diagnosis of the diseases or detection of certain genetic abnormalities before 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Most prenatal genetic tests are completed by drawing a blood sample from the mother.

Diagnostic methods are more effective, accurate and a preferred option for the detection of chromosome abnormalities as compared to the screening methods.

Worldwide Prenatal and Newborn Genetic Testing Market Analysis to 2027 is a specialized and in-depth study of the Prenatal and Newborn Genetic Testing Industry with a focus on the global market trend. The report aims to provide an overview of global Prenatal and Newborn Genetic Testing Market with detailed market segmentation by product/application and geography. The global Prenatal and Newborn Genetic Testing Market is expected to witness high growth during the forecast period. The report provides key statistics on the Market status of the Prenatal and Newborn Genetic Testing players and offers key trends and opportunities in the market.

Get PDF Sample Copy of this Report @ http://bit.ly/2J60owI

Top Dominating Key Players:

1. Abbott
2. Oxford Gene Technology
3. Ravgen.
4. Bio-Rad Laboratories, Inc.
5. Illumina, Inc.
6. SOPHiA GENETICS
7. PerkinElmer Inc.
8. SEBIA
9. Sequenom.
10. Natera, Inc.

The market of prenatal and newborn genetic testing is anticipated to grow with a significant rate in the coming years, owing to factors such as faster increase in genetic abnormalities, rise in fetal mortality, and advancement of healthcare technologies are driving the prenatal and newborn genetic testing market.

Moreover, increase in adoption of new technologies such as non-invasive prenatal testing (NIPT) and non-invasive cell-free fetal DNA-based screening in the developed regions, for early detection of births defects will foster market growth opportunities in the prenatal and newborn genetic testing market.

Key Benefits-

• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Prenatal and Newborn Genetic Testing Market
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa).

Prenatal and Newborn Genetic Testing Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.

The Prenatal and Newborn Genetic Testing Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 – 2027, considering 2018 as the base year and 2018 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Enquiry for Discount @ http://bit.ly/2He07pP

Reason to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Prenatal and Newborn Genetic Testing Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Prenatal and Newborn Genetic Testing, thereby allowing players to develop effective long term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

This release was published on openPR.